NCT00326430

Brief Summary

The purpose of this study is twofold: (1) to compare the effectiveness of two promising treatments for social phobia, a new cognitive therapy model (Clark \& Wells, 1995; Borge et al., 2001) and interpersonal therapy (Lipsitz, Markowitz, \& Cherry, 1997), adapted for inpatient groups; and (2) to study the empirical change processes in these therapies and compare them with the cognitive and interpersonal models of change.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Oct 2001

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2004

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 15, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 16, 2006

Completed
Last Updated

May 16, 2006

Status Verified

May 1, 2006

First QC Date

May 15, 2006

Last Update Submit

May 15, 2006

Conditions

Keywords

Social PhobiaCognitive TherapyInterpersonal TherapyEfficacyProcess-Outcome

Outcome Measures

Primary Outcomes (2)

  • Social Avoidance

  • Social Anxiety

Secondary Outcomes (4)

  • General Anxiety

  • Depression

  • Interpersonal Problems

  • Personality Disorders

Interventions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-IV criteria for social phobia
  • the patient consider social phobia as the main current problem
  • willingness to suspend use of psychotropic medication, alcohol and other substances
  • acceptance of random allocation
  • ability to speak Norwegian
  • age 18-65 years.

You may not qualify if:

  • a history of recurrent major depression currently treated sucessfully with antidepressant medications
  • has immediate need for additional treatment
  • current psychotic disorder or substance abuse
  • organic mental disorder
  • previously treated with similar models

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Modum Bad

Vikersund, Buskerud, N-3370, Norway

Location

MeSH Terms

Conditions

Phobia, Social

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Asle Hoffart, Dr Psychol

    Modum Bad

    STUDY CHAIR
  • Finn-Magnus Borge, Cand Psychol

    Modum Bad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 15, 2006

First Posted

May 16, 2006

Study Start

October 1, 2001

Study Completion

June 1, 2004

Last Updated

May 16, 2006

Record last verified: 2006-05

Locations